|
DISEASE: Gastric or Small Bowel
Select a REGIMEN:
EAP
EFP
FAM
DISEASE: Gastric or Small Bowel
REGIMEN: EAP
ETOPOSIDE [VP-16] 120 mg/m2 per day
IV...D4,5,6
DOXORUBICIN [DOX] 20 mg/m2
IV...D1,7
Caution: Monitor cumulative dose (cardiac toxicity)
CISPLATIN [CDDP] 40 mg/m2 IV over 2
hrs...D2,8
CYCLE: 21-28 days
REFER: Preusser P, et al: J CLIN ONCOL 1989; 7:1310-1317.
DISEASE: Gastric or Small Bowel
REGIMEN: EFP
FLUOROURACIL [5-FU] 900 mg/m2 per day x
5 CIV...D1-5
(Total Dose 4500 mg)
CISPLATIN [CDDP] 20 mg/m2 per day x
5 IV...D1-5
ETOPOSIDE [VP-16] 90 mg/m2 IV/2
hrs...D1,3,5
CYCLE: 24-28 days
REFER: Ajani J, et al: Sixth Intern. Conf. on the Adjuvant Therapy
of Cancer, Proc. & Abstracts 1990; 396-404.
DISEASE: Gastric or Small Bowel
REGIMEN: FAM
FLUOROURACIL [5-FU] 600 mg/m2
IV...D1,8,29,36
DOXORUBICIN [DOX] 30 mg/m2
IV...D1,29
Caution: Monitor cumulative dose (cardiac toxicity)
MITOMYCIN-C [MITC] 10 mg/m2
IV...D1
Caution: Monitor cumulative dose (marrow toxicity,
hemolytic uremic syndrome)
CYCLE: 8 weeks
REFER: MacDonald JS, et al: ANN INTERN MED 1980; 93:533-536.
|
